Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows provided by (used in) operating activities:
Net earnings	$ 523.2	$ 582.2
Adjustments to reconcile net earnings to cash provided by operating activities:
Depreciation and amortization	785.7	798.2
Share-based compensation	45.3	40.1
Goodwill and intangible asset impairment	3.8	59.5
Inventory step-up		32.2
Changes in operating assets and liabilities, net of effect of acquisitions:
Income taxes	(58.3)	(245.4)
Receivables	237.4	346.7
Inventories	(165.2)	(123.9)
Accounts payable and accrued expenses	23.6	(170.6)
Other assets and liabilities	(27.6)	(139.6)
Net cash provided by operating activities	1,367.9	1,179.4
Cash flows used in investing activities:
Additions to instruments	(203.7)	(255.7)
Additions to other property, plant and equipment	(115.2)	(109.8)
Other business combination investments, net of acquired cash		(4.0)
Other investing activities	(15.3)	(13.1)
Net cash used in investing activities	(334.2)	(382.6)
Cash flows provided by (used in) financing activities:
Proceeds from senior notes	749.5
Proceeds from multicurrency revolving facility	400.0	400.0
Payments on multicurrency revolving facility	(400.0)	(400.0)
Redemption of senior notes	(1,150.0)	(500.0)
Proceeds from term loan		192.7
Payments on term loan	(500.0)	(640.0)
Net payments on other debt	(3.9)	(0.9)
Dividends paid to stockholders	(146.2)	(145.0)
Proceeds from employee stock compensation plans	103.4	132.6
Net cash flows from unremitted collections from factoring programs	(54.6)
Business combination contingent consideration payments	(16.7)	(9.1)
Restricted stock withholdings	(3.3)	(7.6)
Debt issuance costs	(4.9)	(0.3)
Net cash used in financing activities	(1,026.7)	(977.6)
Effect of exchange rates on cash and cash equivalents	(6.8)	27.5
Increase (decrease) in cash and cash equivalents	0.2	(153.3)
Cash and cash equivalents, beginning of year	524.4	634.1
Cash and cash equivalents, end of period	$ 524.6	$ 480.8